Skip to content
Home/Companies/MedTech/Galvanize
Galvanize

Galvanize

MedTech·United States·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Galvanize?

Galvanize is an American MedTech company, currently owned by Sofinnova Partners since 2022.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Sofinnova Partners
Investor
Sofinnova Partners
Sofinnova Capital X · 2021 · Life Sciences VC

Key facts

HQUnited States
SectorMedTech
Websitegalvanizetx.com

More from Sofinnova Capital X

Other portfolio companies in the same fund.

DISCO Pharmaceuticals
Active
BiotechGermany· 2023
Freya Biosciences
Freya Biosciences
Active
BiotechDenmark· 2023
May Health
May Health
Active
MedTechFrance· 2023
Nuage Therapeutics
Nuage Therapeutics
Active
BiotechSpain· 2023
T-Therapeutics
T-Therapeutics
Active
BiotechUK· 2023
Catamaran Bio
Catamaran Bio
Active
BiotechUS· 2022

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Galvanize?

Galvanize is currently owned by Sofinnova Partners, through Sofinnova Capital X, since 2022.

When did Sofinnova Partners acquire Galvanize?

Sofinnova Partners acquired Galvanize in 2022.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue